Corona Remedies Limited ranks among the top 30 pharmaceutical companies in the Indian Pharmaceutical Market (IPM
Popular topics to explore
Popular topics to explore
Corona Remedies Limited ranks among the top 30 pharmaceutical companies in the Indian Pharmaceutical Market (IPM
CORONA Corona Remedies Limited ranks among the top 30 pharmaceutical companies in the Indian Pharmaceutical Market (IPM). It focuses heavily on chronic care and therapeutic segments, capturing strong market positions:Women's Healthcare: R…
Stock To Watch
Positives
ADANIENT -To raise Rs 1000cr via NCDs (Strong technical positioning of all group stocks)
ULTRACEMCO , ACC - AMBUJACEM -Cement prices improve in December
IOCL, BPCL, HPCL-Brent crude falls after US invasion of Venezuala
Ambe…
Stocks to Watch – Market Update
Positives
HDFCBANK : Received RBI approval to acquire up to 9.5% stake in INDUSINDBK , providing strategic optionality.
BL Kashyap: Secured a ₹616 crore order, strengthening its order book visibility.
Zydus Life: USFDA accepted a drug…
🧪 Corona Remedies – IPO Listing Overview
CORONA
Corona Remedies has made its market debut, drawing attention due to its strong presence in the chronic and acute pharmaceutical segments in India. The company is known for its branded formulations and consistent growth in domestic…
Corona Remedies IPO
The Corona Remedies IPO looks like a play for quick listing gains rather than a solid long-term investment opportunity. Primarily focused on women's health and chronic medicines domestically, the company's existing manufacturing is already…
Corona Remedies IPO — Everything You Need to Know
Pharma company Corona Remedies is coming out with its IPO from December 8 to December 10. The price band is ₹1,008–₹1,062 per share and the IPO size is ₹655.37 crore (Offer For Sale). Since it’s entirely an OFS, no fresh money goes to the…
Nifty monthly chart - Technical learning
Nifty monthly chart - Technical learning 1) Nifty around all time high 2) Nifty respecting 21 SMA on monthly charts very well 3) Only one corona time was such where 21 and 50 SMA both were broken 4) Now we are extremely bullish on charts…

Expected IPOs in November and December 1st Half (In Crores) ▪ ICICI Prudential AMC : 10,000 ▪ Lenskart : ~7,300 (Announced) ▪ Groww - 6,630 (Announced) ▪ Cleanmax Enviro : 5,000 ▪ Pine Labs : 4,100 (Announced) ▪ PhysicsWallah : 3,920 ▪ Fra…
Bata India reported a consolidated net profit of ₹13.83
BATAINDIA
Net profit :- Standalone net profit at ₹14 crore, compared with ₹52 crore in the same period last year. Down 73% Quarter on Quarter. (include other income of ₹13 crore)
Sales :- Sales down to ₹801 crore from ₹942 crore last qu…

Nifty - Study of Bad Phase
Nifty - Study of Bad Phase 1) Chart for Nifty attached 2) This is monthly chart 3) Blue line indicates SMA 50 4) Historically in bad time Nifty takes support around 50 SMA on Monthly charts. (Blue line) In Corona time this SMA 50 was broke…
